Cellular Physiology and Biochemistry 2014-01-01

Expression of the transcription factor Egr-1 in pancreatic acinar cells following stimulation of cholecystokinin or Gαq-coupled designer receptors.

Anke Kaufmann, Oliver G Rössler, Gerald Thiel

文献索引:Cell Physiol. Biochem. 33(5) , 1411-25, (2014)

全文:HTML全文

摘要

BACKGOUND/AIMS: The injection of cerulein, an analogue of the pancreatic secretagogue cholecystokinin (CCK), induces acute pancreatitis in mice that is accompanied by the synthesis of the transcription factor Egr-1. The signaling cascade that connects cerulein stimulation with enhanced Egr-1 biosynthesis was analyzed.AR42J rat pancreatic acinar cells were used as a model system to measure cerulein-induced Egr-1 biosynthesis. For comparison, the signaling cascade induced by activation of Gαq-coupled designer receptors with the designer drug clozapine-N-oxide (CNO) was investigated.Stimulation of AR42J cells with cerulein induced a robust and transient biosynthesis of Egr-1. The signaling cascade connecting cerulein stimulation with Egr-1 gene expression required elevated levels of cytosolic Ca(2+) and the activation of the protein kinases PKC, Raf and ERK, while expression of MKP-1 prevented Egr-1 biosynthesis in cerulein-stimulated AR42J cells. In addition, ternary complex factors are required to connect cerulein stimulation with enhanced transcription of the Egr-1 gene. Egr-1 biosynthesis induced in CNO-stimulated AR42J pancreatic acinar cells expressing Gαq-coupled designer receptors required identical signaling molecules, although subtle differences were observed in comparison to cerulein/CCK receptor signaling.We propose that overstimulation of the canonical Gαq-induced signaling pathway may be crucial for inducing acute pancreatitis.© 2014 S. Karger AG, Basel.


相关化合物

  • Lorglumide钠盐

相关文献:

Different downstream signalling of CCK1 receptors regulates distinct functions of CCK in pancreatic beta cells.

2015-11-01

[Br. J. Pharmacol. 172 , 5050-67, (2015)]

Involvement of different subtypes of cholecystokinin receptors in opioid antinociception in the mouse.

1995-01-01

[Peptides 16(7) , 1229-34, (1995)]

Identification of N-arachidonylglycine, U18666A, and 4-androstene-3,17-dione as novel insulin Secretagogues.

2005-08-05

[Biochem. Biophys. Res. Commun. 333(3) , 778-86, (2005)]

Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists.

1987-11-01

[Arzneimittelforschung 37 , 1265-1268, (1987)]

Studies of three non-peptide cholecystokinin antagonists (devazepide, lorglumide and loxiglumide) in human isolated alimentary muscle and guinea-pig ileum.

1991-02-01

[Br. J. Pharmacol. 102 , 391-395, (1991)]

更多文献...